Dare Bioscience (DARE) Treasury Shares (2013 - 2026)
Dare Bioscience's (DARE) quarterly Treasury Shares came in at $85.2 million in Q4 2013.
Dare Bioscience (DARE) Treasury Shares (2013 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 1 years of Treasury Shares data on file, last reported at $85.2 million in Q4 2013.
- Quarterly Treasury Shares changed N/A year-over-year to $85.2 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $85.2 million (changed N/A YoY) and the FY2013 annual result came in at $85.2 million, changed N/A from the prior year.
- Treasury Shares steadied at $85.2 million in Q4 2013.
- In the past five years, Treasury Shares ranged from a high of $85.2 million in Q4 2013 to a low of $85.2 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 2.72 Mn |
| 10 | Dare Bioscience | 12.14 Mn | -477,914.15 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145,969.00 |
| Jun 30, 2026 | 145,969.00 |
| Dec 31, 2013 | 85.21 Mn |
| Dec 31, 2013 | 85.21 Mn |